In historic vote, mRNA vaccines go 2 and 0 as FDA experts unanimously back Moderna's Covid-19 vaccine
Come Saturday, the US will likely have two Covid-19 vaccines.
The FDA’s advisory committee on vaccines voted unanimously Thursday — with one abstention — to recommend an emergency use authorization for Moderna’s mRNA-based Covid-19 shot, setting the agency up to likely issue the EUA on Friday. The agency does not have to listen to the committee but usually does.
“The evidence that has been studied in great detail on this vaccine highly outweighs any issues that we’ve seen,” Stanford infectious disease pediatrician Hayley Gans said. “And I think really supports us being able, with the pandemic, move forward and finally provide a safe and effective way of getting to herd immunity.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.